Commercialize advanced avian influenza diagnostics and surveillance technologies.

The 'Nature Communications' article highlights recent breakthroughs in diagnosing and monitoring avian influenza. This opens up significant commercial opportunities for biotech, agritech, and public health companies. They can develop and market new, rapid diagnostic kits, advanced AI-driven surveillance systems for farms, enhanced biosecurity solutions, or invest in R&D for next-generation prevention and control methods, tackling a critical global health and agricultural security need.